TrustCore Financial Services’s Rocket Pharmaceuticals RCKT Stock Holding History

TrustCore Financial Services’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-56	Closed	-$1K	–	943
2020 Q3	$1K	Hold	56	–	–	﹤0.01%	813
2020 Q2	$1K	Hold	56	–	–	﹤0.01%	850
2020 Q1	$1K	Hold	56	–	–	﹤0.01%	842
2019 Q4	$1K	Hold	56	–	–	﹤0.01%	861
2019 Q3	$1K	Hold	56	–	–	﹤0.01%	920
2019 Q2	$1K	Hold	56	–	–	﹤0.01%	881
2019 Q1	$1K	Hold	56	–	–	﹤0.01%	813
2018 Q4	$1K	Hold	56	–	–	﹤0.01%	429
2018 Q3	$1K	Hold	56	–	–	﹤0.01%	809
2018 Q2	$1K	Hold	56	–	–	﹤0.01%	913
2018 Q1	$1K	Hold	56	–	–	﹤0.01%	679
2017 Q4	$1K	Buy	+56	New	+$555	﹤0.01%	656

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

TrustCore Financial Services's RCKT Position: Q4 2020 in Review

TrustCore Financial Services sold out of Rocket Pharmaceuticals (RCKT) in Q4 2020, closing a stake of 56 shares — an estimated $1K sold.

TrustCore Financial Services first reported a position in RCKT in Q4 2017 and held it in 12 quarters. The position peaked at $1K in Q3 2020. 177 funds tracked by Wall St. Rank hold RCKT as of Q4 2020.

TrustCore Financial Services reported no remaining Rocket Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
TrustCore Financial Services sold 56 Rocket Pharmaceuticals shares in Q4 2020, an estimated $1K.
TrustCore Financial Services first reported a position in Rocket Pharmaceuticals in Q4 2017 and held it in 12 quarters.
TrustCore Financial Services's Rocket Pharmaceuticals position peaked at $1K in Q3 2020.
177 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q4 2020.

Based on TrustCore Financial Services's 13F filing for Q4 2020, filed 4 Feb 2021.